Arvinas (ARVN) Other financing activities (2019 - 2023)
Arvinas (ARVN) recorded quarterly Other financing activities of $15.9 million in Q4 2023, down 40.63% quarter-over-quarter from $26.8 million in Q4 2020.
Arvinas (ARVN) Other financing activities (2019 - 2023) Analysis & Trends
Arvinas' Other financing activities history runs 3 years deep, the most recent figure standing at $15.9 million for Q4 2023.
- In Q4 2023, Other financing activities changed N/A year-over-year to $15.9 million; the TTM figure through Dec 2024 stood at $15.9 million (down 62.75% YoY), while the FY2023 annual figure was $17.0 million, changed N/A from the prior year.
- Other financing activities was $15.9 million for Q4 2023 at Arvinas, down from $26.8 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $26.8 million in Q4 2020 to a low of $600000.0 in Q4 2019.
- Historically, Other financing activities has averaged $14.4 million across 3 years, with a median of $15.9 million in 2023.
- Biggest YoY gain for Other financing activities was 4363.88% in 2020; the steepest drop was 4363.88% in 2020.
- A 3-year view of Other financing activities shows it stood at $600000.0 in 2019, then jumped by 4363.88% to $26.8 million in 2020, then slumped by 40.63% to $15.9 million in 2023.
- The last three Other financing activities figures came in at $15.9 million (Q4 2023), $26.8 million (Q4 2020), and $600000.0 (Q4 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 15.90 Mn |
| Dec 31, 2023 | 15.90 Mn |
| Dec 31, 2020 | 26.78 Mn |
| Dec 31, 2020 | 26.78 Mn |
| Dec 31, 2019 | 600,000.00 |
| Dec 31, 2019 | 600,000.00 |